Daiichi Sankyo, a Japanese pharmaceutical company, acquired Ranbaxy Laboratories in 2008 for approximately $4.6 billion. This acquisition was significant as it marked one of the largest foreign takeovers of an Indian pharmaceutical company at that time. Later, in 2014, Sun Pharmaceutical acquired Ranbaxy from Daiichi Sankyo.